17618301

Source:http://linkedlifedata.com/resource/pubmed/id/17618301

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012356, umls-concept:C0012359, umls-concept:C0086045, umls-concept:C0205042, umls-concept:C0244404, umls-concept:C0302350, umls-concept:C1533691
pubmed:issue	2
pubmed:dateCreated	2007-9-10
pubmed:abstractText	Raloxifene improves cardiovascular function. This study examines the hypothesis that therapeutic concentrations of raloxifene augment endothelium-dependent relaxation via up-regulation of eNOS expression and activity in porcine coronary arteries.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-10477535, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-10739502, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-11006795, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-11110106, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-11557681, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-11851576, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-11861033, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-11901050, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-12225729, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-12592230, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-12648026, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-12727966, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-12823948, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-12932604, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-14618093, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-14676219, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-15155963, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-15167278, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-15550571, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-15713909, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-16299554, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-16837676, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-17113071, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-7654222, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-7840287, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-8205663, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-8862147, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-9386140, http://linkedlifedata.com/resource/pubmed/commentcorrection/17618301-9865533
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7502536
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type III, http://linkedlifedata.com/resource/pubmed/chemical/Raloxifene, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0007-1188
pubmed:author	pubmed-author:AuC LCL, pubmed-author:HuangYY, pubmed-author:LaherII, pubmed-author:LeungF PFP, pubmed-author:LeungH SHS, pubmed-author:VanhoutteP MPM, pubmed-author:YanYY, pubmed-author:YungL MLM
pubmed:issnType	Print
pubmed:volume	152
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	223-9
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:17618301-Animals, pubmed-meshheading:17618301-Bradykinin, pubmed-meshheading:17618301-Coronary Vessels, pubmed-meshheading:17618301-Estradiol, pubmed-meshheading:17618301-Estrogen Antagonists, pubmed-meshheading:17618301-Muscle, Smooth, Vascular, pubmed-meshheading:17618301-Nitric Oxide, pubmed-meshheading:17618301-Nitric Oxide Synthase Type III, pubmed-meshheading:17618301-Raloxifene, pubmed-meshheading:17618301-Swine, pubmed-meshheading:17618301-Vasodilation, pubmed-meshheading:17618301-Vasodilator Agents
pubmed:year	2007
pubmed:articleTitle	Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro.
pubmed:affiliation	Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong SAR, China.
pubmed:publicationType	Journal Article, In Vitro, Research Support, Non-U.S. Gov't